These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 29367096

  • 1. Molecular imaging of platelet-derived growth factor receptor-alpha (PDGFRα) in papillary thyroid cancer using immuno-PET.
    Wagner M, Wuest M, Hamann I, Lopez-Campistrous A, McMullen TPW, Wuest F.
    Nucl Med Biol; 2018 Mar; 58():51-58. PubMed ID: 29367096
    [Abstract] [Full Text] [Related]

  • 2. First-Generation Radiolabeled Cyclic Peptides for Molecular Imaging of Platelet-Derived Growth Factor Receptor α.
    Pike S, Wuest M, Lopez-Campistrous A, Hu MY, Derda R, Wuest F, McMullen T.
    Mol Pharm; 2024 Sep 02; 21(9):4648-4663. PubMed ID: 39152916
    [Abstract] [Full Text] [Related]

  • 3. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
    Boyle AJ, Cao PJ, Hedley DW, Sidhu SS, Winnik MA, Reilly RM.
    Nucl Med Biol; 2015 Feb 02; 42(2):71-7. PubMed ID: 25456837
    [Abstract] [Full Text] [Related]

  • 4. Immuno-PET Imaging of EGFR with 64Cu-NOTA Panitumumab in Subcutaneous and Metastatic Nonsmall Cell Lung Cancer Xenografts.
    Sarrami N, Wuest M, Paiva IM, Leier S, Lavasanifar A, Wuest F.
    Mol Pharm; 2024 Nov 04; 21(11):5797-5806. PubMed ID: 39402973
    [Abstract] [Full Text] [Related]

  • 5. Targeting Phosphatidylserine with a 64Cu-Labeled Peptide for Molecular Imaging of Apoptosis.
    Perreault A, Richter S, Bergman C, Wuest M, Wuest F.
    Mol Pharm; 2016 Oct 03; 13(10):3564-3577. PubMed ID: 27608290
    [Abstract] [Full Text] [Related]

  • 6. Autocrine activation of platelet-derived growth factor receptor α in metastatic papillary thyroid cancer.
    Adewuyi EE, Deschenes J, Lopez-Campistrous A, Kattar MM, Ghosh S, McMullen TPW.
    Hum Pathol; 2018 May 03; 75():146-153. PubMed ID: 29408504
    [Abstract] [Full Text] [Related]

  • 7. Noninvasive Detection of HER2 Expression in Gastric Cancer by 64Cu-NOTA-Trastuzumab in PDX Mouse Model and in Patients.
    Guo X, Zhu H, Zhou N, Chen Z, Liu T, Liu F, Xu X, Jin H, Shen L, Gao J, Yang Z.
    Mol Pharm; 2018 Nov 05; 15(11):5174-5182. PubMed ID: 30251865
    [Abstract] [Full Text] [Related]

  • 8. ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer.
    England CG, Jiang D, Hernandez R, Sun H, Valdovinos HF, Ehlerding EB, Engle JW, Yang Y, Huang P, Cai W.
    Mol Pharm; 2017 Oct 02; 14(10):3239-3247. PubMed ID: 28825843
    [Abstract] [Full Text] [Related]

  • 9. Exploring pitfalls of 64Cu-labeled EGFR-targeting peptide GE11 as a potential PET tracer.
    Striese F, Sihver W, Gao F, Bergmann R, Walther M, Pietzsch J, Steinbach J, Pietzsch HJ.
    Amino Acids; 2018 Oct 02; 50(10):1415-1431. PubMed ID: 30039310
    [Abstract] [Full Text] [Related]

  • 10. PET of c-Met in Cancer with ⁶⁴Cu-Labeled Hepatocyte Growth Factor.
    Luo H, Hong H, Slater MR, Graves SA, Shi S, Yang Y, Nickles RJ, Fan F, Cai W.
    J Nucl Med; 2015 May 02; 56(5):758-63. PubMed ID: 25840981
    [Abstract] [Full Text] [Related]

  • 11. Comparison of DOTA and NODAGA as chelators for (64)Cu-labeled immunoconjugates.
    Ghosh SC, Pinkston KL, Robinson H, Harvey BR, Wilganowski N, Gore K, Sevick-Muraca EM, Azhdarinia A.
    Nucl Med Biol; 2015 Feb 02; 42(2):177-83. PubMed ID: 25457653
    [Abstract] [Full Text] [Related]

  • 12. TE1PA as Innovating Chelator for 64Cu Immuno-TEP Imaging: A Comparative in Vivo Study with DOTA/NOTA by Conjugation on 9E7.4 mAb in a Syngeneic Multiple Myeloma Model.
    Navarro AS, Le Bihan T, Le Saëc P, Bris NL, Bailly C, Saï-Maurel C, Bourgeois M, Chérel M, Tripier R, Faivre-Chauvet A.
    Bioconjug Chem; 2019 Sep 18; 30(9):2393-2403. PubMed ID: 31386357
    [Abstract] [Full Text] [Related]

  • 13. 64Cu-Labeled Trastuzumab Fab-PEG24-EGF Radioimmunoconjugates Bispecific for HER2 and EGFR: Pharmacokinetics, Biodistribution, and Tumor Imaging by PET in Comparison to Monospecific Agents.
    Kwon LY, Scollard DA, Reilly RM.
    Mol Pharm; 2017 Feb 06; 14(2):492-501. PubMed ID: 28049295
    [Abstract] [Full Text] [Related]

  • 14. Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma.
    Persson M, Nedergaard MK, Brandt-Larsen M, Skovgaard D, Jørgensen JT, Michaelsen SR, Madsen J, Lassen U, Poulsen HS, Kjaer A.
    J Nucl Med; 2016 Feb 06; 57(2):272-8. PubMed ID: 26429955
    [Abstract] [Full Text] [Related]

  • 15. Pre-clinical evaluation of immunoPET imaging using agonist CD40 monoclonal antibody in pancreatic tumor-bearing mice.
    Aghevlian S, Wu B, Raie MN, Tumbale SK, Kare AJ, Seo JW, Ferrara KW.
    Nucl Med Biol; 2021 Feb 06; 98-99():8-17. PubMed ID: 33962357
    [Abstract] [Full Text] [Related]

  • 16. Practical Immuno-PET Radiotracer Design Considerations for Human Immune Checkpoint Imaging.
    Mayer AT, Natarajan A, Gordon SR, Maute RL, McCracken MN, Ring AM, Weissman IL, Gambhir SS.
    J Nucl Med; 2017 Apr 06; 58(4):538-546. PubMed ID: 27980047
    [Abstract] [Full Text] [Related]

  • 17. Novel radiolabeled peptides for breast and prostate tumor PET imaging: (64)Cu/and (68)Ga/NOTA-PEG-[D-Tyr(6),βAla(11),Thi(13),Nle(14)]BBN(6-14).
    Fournier P, Dumulon-Perreault V, Ait-Mohand S, Tremblay S, Bénard F, Lecomte R, Guérin B.
    Bioconjug Chem; 2012 Aug 15; 23(8):1687-93. PubMed ID: 22770480
    [Abstract] [Full Text] [Related]

  • 18. Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody.
    Dearling JL, Voss SD, Dunning P, Snay E, Fahey F, Smith SV, Huston JS, Meares CF, Treves ST, Packard AB.
    Nucl Med Biol; 2011 Jan 15; 38(1):29-38. PubMed ID: 21220127
    [Abstract] [Full Text] [Related]

  • 19. Platelet derived growth factor receptor alpha mediates nodal metastases in papillary thyroid cancer by driving the epithelial-mesenchymal transition.
    Ekpe-Adewuyi E, Lopez-Campistrous A, Tang X, Brindley DN, McMullen TP.
    Oncotarget; 2016 Dec 13; 7(50):83684-83700. PubMed ID: 27845909
    [Abstract] [Full Text] [Related]

  • 20. PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab.
    Luo H, England CG, Graves SA, Sun H, Liu G, Nickles RJ, Cai W.
    J Nucl Med; 2016 Feb 13; 57(2):285-90. PubMed ID: 26541778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.